Caption Management, LLC Crinetics Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$42.12 - $51.91 $5.05 Million - $6.23 Million
-120,000 Reduced 37.62%
199,000 $8.91 Million
Q1 2024

May 15, 2024
BUY
$34.76 - $46.81 $8.47 Million - $11.4 Million
243,800 Added 324.2%
319,000 $14.9 Million
Q4 2023

Feb 14, 2024
SELL
$25.62 - $37.07 $3.2 Million - $4.63 Million
-124,800 Reduced 62.4%
75,200 $2.68 Million
Q3 2023

Nov 14, 2023
BUY
$15.97 - $30.59 $3.19 Million - $6.12 Million
200,000 New
200,000 $5.95 Million

Others Institutions Holding CRNX

# of Institutions
241
Shares Held
80M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.12B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email